New Drug That Slashes Asthma Attack By 20 Percent Developed

September 17, 2012

Here’s some good news for asthmatics! A new drug, developed by researchers, has been found to reduce the number of asthma attacks by more than 20 percent.

Trials on nearly 1,000 people with uncontrolled asthma showed the drug tiotropium taken through a mist inhaler opened constricted airways and appeared to improve lung function, the Daily Mail reported.

Even those with severe asthma saw the number of attacks cut by 21 percent and the time between attacks extended by a third.

The drug – already licensed for chronic obstructive pulmonary disease, which usually affects smokers – could be available on the NHS in a few years, the report said.

Five million Britons suffer from asthma, with 250,000 diagnosed with a severe form. On an average, three patients die each day during an attack.

The disease is usually treated with a steroid inhaler or tablets, which can have serious side effects including skin thinning, weight gain and osteoporosis.

“People with asthma are anxious about what steroids are doing to them, particularly if they have to take them long term. Having another tool will be useful,” Neil Churchill, of charity Asthma UK, said.

Researcher Dr Richard Russell, a lung specialist at Wexham Park Hospital in Berkshire, said that the drug could be a “new weapon in our armoury.”

Category: Pharmaceuticals

Comments are closed.